Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas aeruginosa
Authors:
- 6 March 2024
- journal article
- research article
- Published by Springer Nature in Arabian Journal for Science and Engineering
- Vol. 49 (7) , 9111-9120
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An UpdateDrugs, 2021
- Pandrug-resistant Pseudomonas sp. expresses New Delhi metallo-β-lactamase-1 and consumes ampicillin as sole carbon sourceClinical Microbiology and Infection, 2021
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA, 2020
- Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015–2016Diagnostic Microbiology and Infectious Disease, 2018
- Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcomeDiagnostic Microbiology and Infectious Disease, 2017
- Antimicrobial susceptibility of 2906 Pseudomonas aeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: Results of the Canadian Ward surveillance study (CANWARD), 2008–2015Diagnostic Microbiology and Infectious Disease, 2017
- Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infectionsClinical Microbiology and Infection, 2016
- Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infectionsJournal of Infection, 2014
- Antimicrobial resistance — A ticking bomb!Indian Pediatrics, 2014
- Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancerCancer, 2005